Sensitivity of ID NOW and RT-PCR for detection of SARS-CoV-2 in an ambulatory population
Date
2021-04-20Journal
eLifePublisher
eLife Sciences PublicationsType
Article
Metadata
Show full item recordAbstract
Diagnosis of SARS-CoV-2 (COVID-19) requires confirmation by reverse transcription-polymerase chain reaction (RT-PCR). Abbott ID NOW provides fast results but has been criticized for low sensitivity. Here we determine the sensitivity of ID NOW in an ambulatory population presented for testing. The study enrolled 785 symptomatic patients, of whom 21 were positive by both ID NOW and RT-PCR, and 2 only by RT-PCR. All 189 asymptomatic patients tested negative. The positive percent agreement between the ID NOW assay and the RT-PCR assay was 91.3%, and negative percent agreement was 100%. The results from the current study were included into a larger systematic review of literature where at least 20 subjects were simultaneously tested using ID NOW and RT-PCR. The overall sensitivity for ID NOW assay was calculated at 84% (95% confidence interval 55-96%) and had the highest correlation to RT-PCR at viral loads most likely to be associated with transmissible infections.Identifier to cite or link to this item
http://hdl.handle.net/10713/15539ae974a485f413a2113503eed53cd6c53
10.7554/eLife.65726
Scopus Count
Related articles
- Multisite Clinical Validation of Isothermal Amplification-Based SARS-CoV-2 Detection Assays Using Different Sampling Strategies.
- Authors: Desai KT, Alfaro K, Mendoza L, Faron M, Mesich B, Maza M, Dominguez R, Valenzuela A, Acosta CD, Martínez M, Felix JC, Masch R, Smith JS, Gabrilovich S, Wu T, Plump M, Novetsky AP, Einstein MH, Douglas NC, Cremer M, Wentzensen N
- Issue date: 2021 Oct 31
- Diagnostic accuracy of the Cepheid Xpert Xpress and the Abbott ID NOW assay for rapid detection of SARS-CoV-2: A systematic review and meta-analysis.
- Authors: Lee J, Song JU
- Issue date: 2021 Jul
- Comparison of abbott ID NOW COVID-19 rapid molecular assay to cepheid xpert xpress SARS-CoV-2 assay in dry nasal swabs.
- Authors: Serei VD, Cristelli R, Joho K, Salaru G, Kirn T, Carayannopoulous MO, Uprety P
- Issue date: 2021 Apr
- Performance of Abbott ID Now COVID-19 Rapid Nucleic Acid Amplification Test Using Nasopharyngeal Swabs Transported in Viral Transport Media and Dry Nasal Swabs in a New York City Academic Institution.
- Authors: Basu A, Zinger T, Inglima K, Woo KM, Atie O, Yurasits L, See B, Aguero-Rosenfeld ME
- Issue date: 2020 Jul 23
- Evaluation of six different rapid methods for nucleic acid detection of SARS-COV-2 virus.
- Authors: Mahmoud SA, Ganesan S, Ibrahim E, Thakre B, Teddy JG, Raheja P, Zaher WA
- Issue date: 2021 Sep